<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7479923" created="13/04/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7479923</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Down-regulation of <term id="T1" lex="NF-kappa_B_protein_level" sem="Other"><term id="T2" lex="NF-kappa_B_protein" sem="Protein_molecule">NF-kappa B protein</term> levels</term> in activated human lymphocytes by <term id="T3" lex="1,25-dihydroxyvitamin_D3" sem="Lipid">1,25-dihydroxyvitamin D3</term> [published erratum appears in Proc Natl Acad Sci U S A 1996 Jan 9;93(1):524]</sentence>
<event id="E1">
<type class="Negative_regulation"/>
<theme idref="T2"/>
<cause idref="T3"/>
<clue><clueType>Down-regulation</clueType> <linkTheme>of</linkTheme> NF-kappa B protein levels <clueLoc>in activated human lymphocytes</clueLoc> <linkCause>by</linkCause> 1,25-dihydroxyvitamin D3 [published erratum appears in Proc Natl Acad Sci U S A 1996 Jan 9;93(1):524]</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The effect of <term id="T4" lex="1,25-dihydroxyvitamin_D3" sem="Lipid">1,25-dihydroxyvitamin D3</term> [<term id="T5" lex="1,25(OH)2)D3" sem="Lipid">1,25(OH)2)D3</term>], a <term id="T6" lex="steroid_hormone" sem="Lipid">steroid hormone</term> with immunomodulating properties, on <term id="T7" lex="nuclear_factor_kappa_B" sem="Protein_molecule">nuclear factor kappa B</term> (<term id="T8" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>) proteins was examined in <term id="T9" lex="in_vitro_activated_normal_human_lymphocyte" sem="Cell_cultured">in vitro activated normal <term id="T10" lex="human_lymphocyte" sem="Cell_natural">human lymphocytes</term></term> by <term id="T11" lex="Western_blot_analysis" sem="Other">Western blot analysis</term>.</sentence>
<event KT="Investigation" id="E2" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T7"/>
<cause idref="T5"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> 1,25-dihydroxyvitamin D3 [1,25(OH)2)D3], a steroid hormone with immunomodulating properties, <linkTheme>on</linkTheme> nuclear factor kappa B (NF-kappa B) proteins was <clueKT>examined</clueKT> <clueLoc>in in vitro activated normal human lymphocytes</clueLoc> <clueExperiment>by Western blot analysis</clueExperiment>.</clue>
</event>
<event KT="Method" id="E29">
<type class="Physiological_process"/>
<theme idref="T10"/>
<clue>The effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2)D3], a steroid hormone with immunomodulating properties, on nuclear factor kappa B (NF-kappa B) proteins was examined in in vitro <clueType>activated</clueType> normal human lymphocytes by Western blot analysis.</clue>
</event>
<sentence id="S3">Over a 72-hr period of activation, the expression of the <term id="T12" lex="50-kDa_NF-kappa_B" sem="Protein_molecule">50-kDa NF-kappa B</term>, <term id="T13" lex="p50" sem="Protein_molecule">p50</term>, and its precursor, <term id="T14" lex="p105" sem="Protein_molecule">p105</term>, was increased progressively.</sentence>
<event id="E3">
<type class="Gene_expression"/>
<theme idref="T12"/>
<clue>Over a 72-hr period of activation, the <clueType>expression</clueType> <linkTheme>of</linkTheme> the 50-kDa NF-kappa B, p50, and its precursor, p105, was increased progressively.</clue>
</event>
<event id="E4">
<type class="Gene_expression"/>
<theme idref="T13"/>
<clue>Over a 72-hr period of activation, the <clueType>expression</clueType> <linkTheme>of</linkTheme> the 50-kDa NF-kappa B, p50, and its precursor, p105, was increased progressively.</clue>
</event>
<event id="E5">
<type class="Gene_expression"/>
<theme idref="T14"/>
<clue>Over a 72-hr period of activation, the <clueType>expression</clueType> <linkTheme>of</linkTheme> the 50-kDa NF-kappa B, p50, and its precursor, p105, was increased progressively.</clue>
</event>
<event LT="Propositional" id="E6">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<clue><clueTime>Over a 72-hr period of activation</clueTime>, the expression of the 50-kDa NF-kappa B, p50, and its precursor, p105, was <clueType>increased</clueType> progressively.</clue>
</event>
<event LT="Propositional" id="E7">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<clue><clueTime>Over a 72-hr period of activation</clueTime>, the expression of the 50-kDa NF-kappa B, p50, and its precursor, p105, was <clueType>increased</clueType> progressively.</clue>
</event>
<event LT="Propositional" id="E8">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<clue><clueTime>Over a 72-hr period of activation</clueTime>, the expression of the 50-kDa NF-kappa B, p50, and its precursor, p105, was <clueType>increased</clueType> progressively.</clue>
</event>
<sentence id="S4">When <term id="A1" sem="Cell_natural">cells</term> were activated in the presence of <term id="T15" lex="1,25(OH)2D3" sem="Lipid">1,25(OH)2D3</term>, the levels of the <term id="A2" sem="Protein_molecule">mature protein</term> as well as its <term id="A3" sem="Protein_molecule">precursor</term> were decreased.</sentence>
<event KT="Method" id="E9">
<type class="Physiological_process"/>
<theme idref="T10"/>
<cause idref="T15"/>
<clue>When <corefTheme>cells</corefTheme> were <clueType>activated</clueType> <linkCause>in the presence of</linkCause> 1,25(OH)2D3, the levels of the mature protein as well as its precursor were decreased.</clue>
</event>
<event LT="Propositional" id="E10">
<type class="Negative_regulation"/>
<theme idref="A2"/>
<clue><linkCause>When</linkCause> cells were activated in the presence of 1,25(OH)2D3, the levels of the mature protein as well as its precursor were <clueType>decreased</clueType>.</clue>
</event>
<event LT="Propositional" id="E11">
<type class="Negative_regulation"/>
<theme idref="A3"/>
<clue><linkCause>When</linkCause> cells were activated in the presence of 1,25(OH)2D3, the levels of the mature protein as well as its precursor were <clueType>decreased</clueType>.</clue>
</event>
<sentence id="S5">The effect of the hormone on the levels of <term id="T16" lex="p50" sem="Protein_molecule">p50</term> was demonstrable in the <cons id="T17" lex="(AND cytosolic_compartment nuclear_compartment)" sem="(AND Cell_component Cell_component)"><frag id="F1">cytosolic</frag> and <frag id="F2">nuclear</frag> <frag id="F3">compartments</frag></cons>; it required between 4 and 8 hr and was specific, as <term id="T18" lex="25-hydroxyvitamin_D3" sem="Lipid">25-hydroxyvitamin D3</term> and <term id="T19" lex="24,25-dihydroxyvitamin_D3" sem="Lipid">24,25-dihydroxyvitamin D3</term> were ineffective.</sentence>
<event LT="Propositional" id="E31">
<type class="Regulation"/>
<theme idref="T16"/>
<cause idref="T15"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> <corefCause>the hormone</corefCause> <linkTheme>on</linkTheme> the levels of p50 was demonstrable <clueLoc>in the cytosolic</clueLoc> and nuclear <clueLoc>compartments</clueLoc>; it required <clueTime>between 4 and 8 hr</clueTime> and was specific, as 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were ineffective.</clue>
</event>
<event LT="Propositional" id="E13">
<type class="Regulation"/>
<theme idref="T16"/>
<cause idref="T15"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> <corefCause>the hormone</corefCause> <linkTheme>on</linkTheme> the levels of p50 was demonstrable <clueLoc>in</clueLoc> the cytosolic and <clueLoc>nuclear compartments</clueLoc>; it required <clueTime>between 4 and 8 hr</clueTime> and was specific, as 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were ineffective.</clue>
</event>
<event LT="Propositional" Polarity="Negative" assertion="non-exist" id="E15">
<type class="Regulation"/>
<theme idref="T16"/>
<cause idref="T18"/>
<clue>The effect of the hormone on the levels of p50 was demonstrable in the cytosolic and nuclear compartments; it required between 4 and 8 hr and was specific, as 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were <clueType><cluePolarity>ineffective</cluePolarity></clueType>.</clue>
</event>
<event LT="Propositional" Polarity="Negative" assertion="non-exist" id="E16">
<type class="Regulation"/>
<cause idref="T19"/>
<clue>The effect of the hormone on the levels of p50 was demonstrable in the cytosolic and nuclear compartments; it required between 4 and 8 hr and was specific, as 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were <clueType><cluePolarity>ineffective</cluePolarity></clueType>.</clue>
<comment>NO THEME</comment></event>
<sentence id="S6">Besides <term id="T20" lex="p50" sem="Protein_molecule">p50</term>, <term id="T21" lex="1,25(OH)2D3" sem="Lipid">1,25(OH)2D3</term> decreased the levels of another <term id="T22" lex="NF-kappa_B_protein" sem="Protein_molecule">NF-kappa B protein</term>, namely <term id="T23" lex="c-rel" sem="Protein_molecule">c-rel</term>.</sentence>
<event LT="Propositional" id="E17">
<type class="Negative_regulation"/>
<theme idref="T20"/>
<cause idref="T21"/>
<clue>Besides p50, 1,25(OH)2D3 <clueType>decreased</clueType> the levels of another NF-kappa B protein, namely c-rel.</clue>
</event>
<event LT="Propositional" id="E18">
<type class="Negative_regulation"/>
<theme idref="T23"/>
<cause idref="T21"/>
<clue>Besides p50, 1,25(OH)2D3 <clueType>decreased</clueType> the levels <linkTheme>of</linkTheme> <corefTheme>another NF-kappa B protein</corefTheme>, namely c-rel.</clue>
</event>
<sentence id="S7">In addition, <term id="T24" lex="1,25(OH)2D3" sem="Lipid">1,25(OH)2D3</term> decreased the abundance of a <term id="T25" lex="specific_DNA-protein_complex" sem="Protein_complex">specific DNA-protein complex</term> formed upon incubation of <term id="A4" sem="Cell_component">nuclear extracts from activated lymphocytes</term> with a labeled <term id="T26" lex="NF-kappa_B_DNA_binding_motif" sem="Protein_domain_or_region"><term id="T27" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> DNA binding motif</term>.</sentence>
<event KT="Method" id="E19">
<type class="Artificial_process"/>
<theme idref="A4"/>
<theme idref="T26"/>
<clue>In addition, 1,25(OH)2D3 decreased the abundance of a specific DNA-protein complex formed upon <clueType>incubation</clueType> <linkTheme>of</linkTheme> nuclear extracts from activated lymphocytes <linkTheme>with</linkTheme> a labeled NF-kappa B DNA binding motif.</clue>
<comment>TPS: A4</comment></event>
<event id="E20">
<type class="Protein_metabolism"/>
<theme idref="T25"/>
<clue>In addition, 1,25(OH)2D3 decreased the abundance of a specific DNA-protein complex <clueType>formed</clueType> upon incubation of nuclear extracts from activated lymphocytes with a labeled NF-kappa B DNA binding motif.</clue>
</event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="E19"/>
<clue>In addition, 1,25(OH)2D3 decreased the abundance of a specific DNA-protein complex formed <linkCause>upon</linkCause> incubation of nuclear extracts from activated lymphocytes with a labeled NF-kappa B DNA binding motif.</clue>
<comment>NO CLUETYPE</comment></event>
<event LT="Propositional" id="E22">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T24"/>
<clue>In addition, 1,25(OH)2D3 <clueType>decreased</clueType> the abundance of a specific DNA-protein complex formed <clueExperiment>upon incubation of nuclear extracts from activated lymphocytes with a labeled NF-kappa B DNA binding motif</clueExperiment>.</clue>
</event>
<sentence id="S8">Further, <term id="T28" lex="1,25(OH)2D3" sem="Lipid">1,25(OH)2D3</term> inhibited the transcriptional activity of <term id="T29" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> in <term id="T30" lex="Jurkat_cell" sem="Cell_cultured">Jurkat cells</term> transiently transfected with a <term id="A6" sem="DNA_domain_or_region"><term id="T31" lex="construct" sem="DNA_molecule">construct</term> containing four <term id="A7" sem="DNA_domain_or_region"><term id="T32" lex="tandem_repeat" sem="DNA_domain_or_region">tandem repeats</term> of the <term id="T33" lex="NF-kappa_B_binding_sequence" sem="DNA_domain_or_region"><term id="T34" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> binding sequence</term> of the <term id="T35" lex="immunoglobulin_kappa_light_chain_gene" sem="DNA_domain_or_region">immunoglobulin kappa light chain gene</term></term> linked to the <term id="T36" lex="chloramphenicol_acetyltransferase_reporter_gene" sem="DNA_domain_or_region"><term id="T37" lex="chloramphenicol_acetyltransferase" sem="Protein_molecule">chloramphenicol acetyltransferase</term> reporter gene</term></term>.</sentence>
<event id="E12">
<type class="Gene_expression"/>
<theme idref="A6"/>
<clue>Further, 1,25(OH)2D3 inhibited the transcriptional activity of NF-kappa B <clueLoc>in Jurkat cells</clueLoc> <clueType>transiently transfected</clueType> <linkTheme>with</linkTheme> a construct containing four tandem repeats of the NF-kappa B binding sequence of the immunoglobulin kappa light chain gene linked to the chloramphenicol acetyltransferase reporter gene.</clue>
<comment>TPS: A6; ARTIFICIAL</comment></event>
<event id="E14">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<clue>Further, 1,25(OH)2D3 inhibited the transcriptional activity of NF-kappa B <clueLoc>in Jurkat cells</clueLoc> <clueType>transiently transfected</clueType> <linkTheme>with</linkTheme> a construct containing four tandem repeats of the NF-kappa B binding sequence of the immunoglobulin kappa light chain gene linked to the chloramphenicol acetyltransferase reporter gene.</clue>
</event>
<event LT="Propositional" id="E24">
<type class="Negative_regulation"/>
<theme idref="T29"/>
<cause idref="T28"/>
<clue>Further, 1,25(OH)2D3 <clueType>inhibited</clueType> the transcriptional activity of NF-kappa B <clueLoc>in Jurkat cells</clueLoc> <clueExperiment>transiently transfected with a construct containing four tandem repeats of the NF-kappa B binding sequence of the immunoglobulin kappa light chain gene linked to the chloramphenicol acetyltransferase reporter gene.</clueExperiment></clue>
</event>
<event KT="Other" id="E25">
<type class="Positive_regulation"/>
<cause idref="T29"/>
<clue>Further, 1,25(OH)2D3 inhibited the <clueType>transcriptional activity</clueType> <linkCause>of</linkCause> NF-kappa B <clueLoc>in Jurkat cells</clueLoc> transiently transfected with a construct containing four tandem repeats of the NF-kappa B binding sequence of the immunoglobulin kappa light chain gene linked to the chloramphenicol acetyltransferase reporter gene.</clue>
<comment>NO THEME</comment></event>
<sentence id="S9">These observations demonstrate directly that there is <term id="T38" lex="de_novo_synthesis" sem="Other">de novo synthesis</term> of <term id="T39" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> during human <term id="T40" lex="lymphocyte_activation" sem="Other"><term id="A5" sem="Cell_natural">lymphocyte</term> activation</term> and suggest that this process is hormonally regulated.</sentence>
<event KT="Analysis" LT="Propositional" id="E26">
<type class="Gene_expression"/>
<theme idref="T39"/>
<clue>These observations <clueKT>demonstrate</clueKT> directly that there is de novo <clueType>synthesis</clueType> <linkTheme>of</linkTheme> NF-kappa B <clueTime>during human lymphocyte activation</clueTime> and suggest that this process is hormonally regulated.</clue>
</event>
<event KT="Method" id="E27">
<type class="Physiological_process"/>
<theme idref="A5"/>
<clue>These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte <clueType>activation</clueType> and suggest that this process is hormonally regulated.</clue>
</event>
<event CL="L2" KT="Analysis" LT="Propositional" id="E28" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E26"/>
<cause idref="T28"/>
<clue>These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and <clueKT><clueCL>suggest</clueCL></clueKT> that <corefTheme>this process</corefTheme> is <corefCause>hormonally</corefCause> <clueType>regulated</clueType>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
